Özkan Epöztürk, PınarUslu, NeslihanTaş, ZahideSasani, HadiKüçükkaya, ReyhanYağcı, BuketSözen, Semih2023-04-202023-04-2020222651-31372651-3153https://doi.org/10.4274/eamr.galenos.2021.47965https://search.trdizin.gov.tr/yayin/detay/533019https://hdl.handle.net/20.500.11776/11312Objective: Dynamic changes in the number of eosinophils are observed during the diagnosis and follow-up in coronavirus disease-2019(COVID-19). Our aim was to show the role of the absolute eosinophil count in the diagnosis of COVID-19 and the relationship with diseaseseverity and prognosis.Methods: In this study, 191 patients (130 inpatients, 61 outpatients) diagnosed with COVID-19 pneumonia with the polymerase chain reactiontest and lung computed tomography; and 22 patients with positive influenza test were included as the control group. All demographic,biochemical data, clinical and radiological characteristics were recorded.Results: The mean eosinophils on first day of the inpatient COVID-19 group were found to be statistically lower than the influenza group andthe ambulatory groups (p=0.001, p=0.0001).Conclusion: A low eosinophil count in complete blood count, can aid in the early diagnosis of infection. Persistent eosinopenia progresseswith disease severity and may help determine the prognosis of the disease.en10.4274/eamr.galenos.2021.47965info:eu-repo/semantics/openAccessArticle382117124533019